Saturday, November 12, 2016

BRIEF-Novo's Tresiba shows lower variability in glucose-lowering effect in study

* Says Tresiba demonstrated lower day-to-day and within-day

variability in glucose-lowering effect compared with insulin

glargine u300

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)